Author pages are created from data sourced from our academic publisher partnerships and public sources.
Share This Author
EP4 as a Therapeutic Target for Aggressive Human Breast Cancer
- M. Majumder, P. Nandi, A. Omar, K. Ugwuagbo, P. Lala
- International journal of molecular sciences
- 29 March 2018
A case is made for EP4 as a promising newer therapeutic target for treating breast cancer, and it is suggested that EP4A will likely produce the highest benefit in aggressive breast cancers, when combined with other newer agents, such as inhibitors of programmed cell death (PD)-1 or PD-L1. Expand
Comparative study of the hepatotoxic, genotoxic and carcinogenic effects of praziquantel distocide & the natural myrrh extract Mirazid on adult male albino rats.
- A. Omar, G. Elmesallamy, S. Eassa
- Journal of the Egyptian Society of Parasitology
- 1 April 2005
It was found that praziquantel induced a significant increase in the mean values of AST, ALT and bilirubin with areas of hyaline degeneration, fatty changes, dysplasia and necrosis in the liver sections and Mirazid seemed to be a safe and promising antiparasitic drug, free from hepatotoxic, genotoxic and carcinogenic effects. Expand
A comparative study between magnesium sulphate and dexmedetomidine for deliberate hypotension during middle ear surgery
It was concluded that both magnesium sulphate and dexmedetomidine successfully induced deliberate hypotension in patients undergoing middle ear surgery but magnesium sulphATE was associated with shorter recovery time and earlier discharge from the PACU. Expand
Postoperative continuous transversus abdominis plane block vs continuous wound infusion of levobupivacaine in females undergoing open gynecologic procedures
- A. Omar
- 1 October 2013
Continuous bilateral TAP block and CWI can decrease PCA morphine consumption in the first postoperative 48 h when compared to placebo in women undergoing gynecologic surgery through transverse lower abdominal incision. Expand
Prospective, randomized controlled study to assess the role of dexmedetomidine in patients with supratentorial tumors undergoing craniotomy under general anesthesia.
- R. Soliman, A. R. Hassan, A. Rashwan, A. Omar
- Middle East journal of anaesthesiology
- 1 February 2011
Continuous intraoperative infusion of dexmedetomidine during craniotomy for supratentorial tumors under general anesthesia maintained the hemodynamic stability, reduced sevoflurane and fentanyl requirements, decreased intracranial pressure, and improved significantly the outcomes. Expand
Prospective, randomized study to assess the role of dexmedetomidine in patients with supratentorial tumors undergoing craniotomy under general anaesthesia.
Assessment of the perioperative effect of intraoperative infusion of dexmedetomidine in patients with supratentorial tumors undergoing craniotomy under general anaesthesia maintained the haemodynamic stability, reduced sevoflurane and fentanyl requirements, decreased intracranial pressure, and improved significantly the outcomes. Expand
Psoas Compartment Block for Acute Postoperative Pain Management After Hip Surgery in Pediatrics: A Comparative Study With Caudal Analgesia
Use of single- shot PCB is superior to single-shot caudal block regarding length of postoperative analgesia and cumulative dose of morphine in small children undergoing open hip reduction/osteotomies. Expand
Can systemic lidocaine be used in controlled hypotension? A double-blinded randomized controlled study in patients undergoing functional endoscopic sinus surgery
- A. Omar
- 1 October 2013
This study showed the ability of intravenous lidocaine infusion of 1.5 mg/kg/h to produce controlled hypotension in patients undergoing FESS and the superiority of this technique over placebo to achieve favorable surgical field scoring. Expand
Effect of intravenous lidocaine infusion on sevoflurane requirements as monitored by bispectral index: A randomized double-blinded controlled study
In conclusion, intravenous lidocaine administration, during maintenance of general anesthesia, can decrease BIS-guided sevoflurane requirements. Expand
Sunitinib alone or in combination with chemotherapy for the treatment of advanced breast cancer: A systematic review and meta-analysis.
Current evidence shows that sunitinib, either alone or in combination with chemotherapy, has no clinical benefit for patients with advanced breast cancer. Expand